Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T65868
(Former ID: TTDNS00584)
|
|||||
Target Name |
RNA synthesis (hRNA synth)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Successful target
|
[1] | ||||
Disease | [+] 2 Target-related Diseases | + | ||||
1 | Mineral excesses [ICD-11: 5B91] | |||||
2 | Testicular cancer [ICD-11: 2C80] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Approved Drug(s) | [+] 1 Approved Drugs | + | ||||
1 | Plicamycin | Drug Info | Approved | Testicular cancer | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Modulator | [+] 1 Modulator drugs | + | ||||
1 | Plicamycin | Drug Info | [1] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Role of magnesium ion in mithramycin-DNA interaction: binding of mithramycin-Mg2+ complexes with DNA. Biochemistry. 1995 Jan 31;34(4):1376-85. | |||||
REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.